As shoppers have turned to cheaper alternatives to beat inflation, retailers from CVS to Target and Walmart have invested ...

People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of ...

Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday.